Dihexa vs Semax
Side-by-side comparison of Dihexa, Semax — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Dihexa Dihexa (PNB-0408) Cognitive | Semax Semax (Heptapeptide ACTH Analogue) Cognitive |
|---|---|---|
| Basics | ||
| Molecular type | HGF/MET Potentiator | ACTH-Derived Neuropeptide |
| Amino acids | — | 7 |
| Molecular weight | 413.5 Da | 813.9 Da |
| Half-life | Long-acting (days) | ~minutes (nasal); longer CNS retention |
| Route(s) | Oral, Transdermal, Subcutaneous (research) | Intranasal, Subcutaneous |
| Mechanism & Research | ||
| Primary mechanism | Dihexa binds to and potentiates the HGF/MET signalling axis. HGF-MET signalling drives synaptogenesis — the formation of new neural connections. By dramatically amplifying this pathway, Dihexa promotes dendritic spine de… | Semax's primary mechanism involves upregulation of brain-derived neurotrophic factor (BDNF) — a neurotrophin critical for neuronal survival, synaptic plasticity, and neurogenesis. In animal models, Semax increases BDNF m… |
| Research status | Research Compound | Research Compound |
| Evidence summary | Dihexa research is primarily from Washington State University's McCoy group. Dramatic findings in animal models have generated interest, but human clinical trials are not yet published. Anecdotal reports from users are b… | Semax has been investigated in Russian clinical research since the 1980s. It has been approved in Russia as a drug for stroke, TBI, and cognitive decline. Western research interest has grown, but large RCTs meeting curre… |
| Protocol & Dosing | ||
| Typical dose | 10–15 mg/day (oral or transdermal) | 200–600 mcg/day (intranasal) |
| Frequency | Daily or 5 days on / 2 days off | 1–2x daily |
| Duration | 4–8 weeks | 2–4 weeks cycles |
| Timing | Morning | Morning (or morning + midday); avoid evening to prevent sleep disruption |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Not Prohibited | Not Prohibited |
| Deeper reading | ||
| Related peptides | Semax, Selank, P21 | Selank, Dihexa, P21 |
| Full profile | Read full Dihexa profile → | Read full Semax profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.